Nature Biomedical Engineering, Published online: 09 September 2026; doi:10.1038/s41551-026-01790-9 A generative protein design workflow addresses important challenges with de novo protein engineering of chimaeric antigen receptors (CARs) to improve targeting of proteins important in cancer and create more effective CAR T therapies.